Effect [qlco]
Estrogen Replacement Therapy [topp]
Progestagen [horm, phsu, strd]
fibrinolytic [topp]
System [ftcn]
Coagulation [ortf]
inhibitors [chvf]
postmenopausal [tmco]
Status [qlco]
Objective [inpr]
Aim [idcn]
Study [mnob]
To [qlco]
Several [qnco]
fibrinolytic [topp]
Components [mnob]
Coagulation [ortf]
inhibitors [chvf]
postmenopausal [tmco]
Women [popg]
To [qlco]
Evaluate [ftcn]
Effect [qlco]
Hormone replacement therapy [topp]
Study Design [resa]
Several [qnco]
haemostatic [ortf]
Parameters [fndg]
Evaluated [ftcn]
postmenopausal [tmco]
Women [popg]
months [tmco]
Hormone Therapy [topp]
Result [ftcn]
Increase [ftcn]
Plasma [bdsu]
fibrinolytic [topp]
activity [dora]
Increase [ftcn]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
Decrease [qlco]
Observed [ftcn]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
Decrease [qlco]
Protein S [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Detected [fndg]
therapy [ftcn]
Modification [ftcn]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
Inhibitor [qlco]
Activated protein C [aapp, enzy]
Complexes [chvs]
Urokinase [aapp, enzy, phsu]
activity [dora]
Plasminogen [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Detected [fndg]
Conclusions [idcn]
Increase [ftcn]
fibrinolytic [topp]
activity [dora]
Decrease [qlco]
Lipoprotein (a) [aapp, bacs]
Level [qlco]
Observed [ftcn]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
Help [socb]
Decrease [qlco]
Risk [qlco]
Coronary Disease [dsyn]
Associated [qlco]
Postmenopausal state [tmco]
